An overview of chemotherapy for mesothelioma Journal Article


Author: Krug, L. M.
Article Title: An overview of chemotherapy for mesothelioma
Abstract: Effective chemotherapy for mesothelioma is currently available. Hopefully, it will provide a springboard for further advances, such as in the areas of targeted therapies and combined modality treatment because there remains a lot of room for improvement. © 2005 Elsevier Inc. All rights reserved.
Keywords: cancer chemotherapy; treatment outcome; clinical trial; fatigue; neutropenia; review; intensity modulated radiation therapy; sorafenib; cisplatin; doxorubicin; antineoplastic agents; capecitabine; gemcitabine; paclitaxel; methotrexate; temozolomide; topotecan; antineoplastic agent; carboplatin; unindexed drug; edema; bone marrow suppression; etoposide; gastrointestinal symptom; thrombocytopenia; granulocyte macrophage colony stimulating factor; cyclophosphamide; vincristine; ifosfamide; vinblastine; docetaxel; irinotecan; febrile neutropenia; drug delivery systems; drug mechanism; systematic review; cardiotoxicity; mitoxantrone; semaxanib; vatalanib; malignant mesothelioma; mesothelioma; mitomycin c; perioperative period; navelbine; drug dose regimen; folinate calcium; pemetrexed; meta analysis; peritoneum mesothelioma; raltitrexed; trimetrexate; razoxane; imidazole; edatrexate; amminedichloro(2 methylpyridine)platinum; ranpirnase
Journal Title: Hematology/Oncology Clinics of North America
Volume: 19
Issue: 6
ISSN: 0889-8588
Publisher: Elsevier Inc.  
Date Published: 2005-12-01
Start Page: 1117
End Page: 1136
Language: English
DOI: 10.1016/j.hoc.2005.09.010
PUBMED: 16325127
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 16" - "Export Date: 24 October 2012" - "CODEN: HCNAE" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Lee M Krug
    178 Krug